Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372437
Status:
COMPLETED
Last Update Posted:
2015-07-01
First Post:
2006-09-05
Brief Title:
A Phase III Study of MGCD0103 MG-0103 in Combination With Gemcitabine
Sponsor:
Mirati Therapeutics Inc
Organization:
Mirati Therapeutics Inc